Patents by Inventor Andrew Osnowski

Andrew Osnowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR ASSESSING THE COMPATIBILITY OF PRODUCTION FLUID ADDITIVES
    Publication number: 20210255163
    Abstract: A method of determining the suitably of corrosion inhibitors, or other additives in the presence of corrosion inhibitor, for a given fluid environment. The method including determining if there is a difference in the presence or level of micelles between a fluid sample to which corrosion inhibitor has been added either alone or to which corrosion inhibitor and at least one additional fluid additive or additives have been added. The method can be used to determine the compatibility of fluid additives.
    Type: Application
    Filed: June 17, 2019
    Publication date: August 19, 2021
    Inventors: Scott RANKIN, Andrew OSNOWSKI, Emma PERFECT, Harry GROVER, Fiona Carson
  • DETECTION OF PRODUCTION FLUID ADDITIVES USING SPIKING
    Publication number: 20200371039
    Abstract: A method of detecting production fluid additives in a fluid conducting and containment system when the additive is below its effective dose. The method includes adding an additional surfactant containing chemical to a fluid until the point of micelle formation in order to determine the amount of additive in a system when it is below its effective dose.
    Type: Application
    Filed: August 3, 2018
    Publication date: November 26, 2020
    Inventors: Scott RANKIN, Andrew OSNOWSKI, Fiona CARSON
  • BIOCIDE DETECTION
    Publication number: 20200371028
    Abstract: A method and kit for the detection of biocide levels in a fluid conducting and containment system. Using micelle formation in the presence of a marker solution to determine if a biocide is at its effective dose throughout a fluid conducting and containment system.
    Type: Application
    Filed: August 3, 2018
    Publication date: November 26, 2020
    Inventors: Andrew OSNOWSKI, Scott RANKIN, Fiona CARSON, Mohsen ACHOUR, Emma PERFECT
  • N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds
    Patent number: 7427627
    Abstract: The present invention relates to 2-substituted 4-heteroaryl-pyrimidines, their preparation, pharmaceutical compositions containing them and their use as inhibitors of cyclin-dependent kinases (CDKs) and hence their use in the treatment of proliferative disorders such as cancer, leukaemia, psoriasis and the like.
    Type: Grant
    Filed: May 11, 2006
    Date of Patent: September 23, 2008
    Assignee: Cyclacel Limited
    Inventors: Shudong Wang, Christopher Meades, Andrew Osnowski, Gavin Wood, Peter Martin Fischer
  • N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds
    Patent number: 7388015
    Abstract: The present invention relates to 2-substituted 4-heteroaryl-pyrimidines, their preparation, pharmaceutical compositions containing them and their use as inhibitors of cyclin-dependent kinases (CDKs) and hence their use in the treatment of proliferative disorders such as cancer, leukaemia, psoriasis and the like.
    Type: Grant
    Filed: March 26, 2004
    Date of Patent: June 17, 2008
    Assignee: Cyclacel Limited
    Inventors: Shudong Wang, Christopher Meades, Andrew Osnowski, Gavin Wood, Peter Martin Fischer
  • N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds
    Publication number: 20060199830
    Abstract: The present invention relates to 2-substituted 4-heteroaryl-pyrimidines, their preparation, pharmaceutical compositions containing them and their use as inhibitors of cyclin-dependent kinases (CDKs) and hence their use in the treatment of proliferative disorders such as cancer, leukaemia, psoriasis and the like.
    Type: Application
    Filed: May 11, 2006
    Publication date: September 7, 2006
    Applicant: Cyclacel Limited
    Inventors: Shudong Wang, Christopher Meades, Andrew Osnowski, Gavin Wood, Peter Martin Fischer
  • N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds
    Publication number: 20040259894
    Abstract: The present invention relates to 2-substituted 4-heteroaryl-pyrimidines, their preparation, pharmaceutical compositions containing them and their use as inhibitors of cyclin-dependent kinases (CDKs) and hence their use in the treatment of proliferative disorders such as cancer, leukemia, psoriasis and the like.
    Type: Application
    Filed: March 26, 2004
    Publication date: December 23, 2004
    Inventors: Shudong Wang, Christopher Meades, Andrew Osnowski, Gavin Wood, Peter Martin Fischer